Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-14 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-24 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
CLSN | Celsion | 1.71 | -0.14 | -7.57% | 125.2M |
You can purchase shares of Celsion (NASDAQ: CLSN) through any online brokerage.
Other companies in Celsion’s space includes: Atossa Therapeutics (NASDAQ:ATOS), GlycoMimetics (NASDAQ:GLYC) and BioLine Rx (NASDAQ:BLRX).
The latest price target for Celsion (NASDAQ: CLSN) was reported by Oppenheimer on 2020-07-16. The analyst firm set a price target for 0.00 expecting CLSN to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Celsion (NASDAQ: CLSN) is $1.71 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Celsion.
There is no upcoming split for Celsion.